Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Financings in Brief: Vasomedical

This article was originally published in The Gray Sheet

Executive Summary

Vasomedical: Developer of the EECP (Enhanced External Counterpulsation) technology for eliminating symptoms of chronic stable angina announces that Banca del Gottardo has converted "on behalf of its clients" all outstanding 7% $4 mil. convertible debentures due July 7, 2000. The debentures were converted into 4 mil. shares of Vasomedical common stock, the firm says. With the conversion, Vasomedical says it has "eliminated all of its long- term indebtedness, is not obligated to make any interest payments (the first of which, amounting to $280,000 was due in July) and has strengthened its net worth by over $3.5 mil."...



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts